New antiarrhythmic agents. 2. Amide alkyl alpha-amino xylidides.
The synthesis of a series of N-alkyl 2-amino 2',6'-xylidides is described. The method involved coupling of the N-alkyl-2',6'-xylidine with the appropriate 2-haloacyl halide, followed by ammonolysis. Alternatively, alkylation of the 2-phthalimido 2',6'-xylidide with NaH and the alkyl halide followed by hydrazinolysis was used. All compounds were evaluated for their ability to protect mice against chloroform-induced ventricular fibrillation. The compounds were generally more potent antifibrillatory agents than the corresponding secondary amides. All were more potent than tocainide and several showed less CNS toxicity. Five compounds were further evaluated in dogs with ventricular arrhythmias resulting from myocardial infarction. N-Ethyl-2-aminoaceto-4'-propoxy-2',6'-xylidide was as potent as lidocaine and produced less CNS toxicity.
D000814:Aniline Compounds / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000138:chemical synthesis*; D001281:Atrial Fibrillation / Q000517:prevention & control; D055598:Chemical Phenomena; D002621:Chemistry; D002725:Chloroform / Q000633:toxicity; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D051379:Mice; D013329:Structure-Activity Relationship; D014992:Xylenes / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D014992:Xylenes; D002725:Chloroform